Compare InMode Ltd (INMD) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
InMode Ltd vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? InMode Ltd trades at $14.22 (market cap $809.93M), while iShares Broad USD Investment Grade Corporate Bond trades at $48.77 (market cap $17.53B). The key difference: iShares Broad USD Investment Grade Corporate Bond is far larger — about 21.6× InMode Ltd's market cap, and InMode Ltd is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 28 Days and iShares Broad USD Investment Grade Corporate Bond for 44 Days on average.
| INMD | USIG | |
|---|---|---|
Market Cap | $809.93M | $17.53B |
Volume | 365,490 | 4,695,583 |
Sector | Health | Fixed Income |
52-Week High | $16.62 | $52.69 |
52-Week Low | $12.76 | $48.54 |
Typical Hold Time | 28 Days | 44 Days |
Enterprise Value | $313.27M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.20, up 1.36% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with 76.52% gross margins and 20.69% net income margin, though Q1 2026 earnings missed expectations. Recent news includes product innovation with Morpheus8 Cool launch and an unsolicited acquisition offer from Steel Partners at $16.75 per share. Analyst consensus is divided with 45% buy ratings amid ongoing shareholder activism concerns.
The stock presents value opportunity with attractive valuation multiples (P/E 11.63, EV/EBITDA 4.48) but faces near-term execution risks. Key catalysts include Q3 earnings delivery and resolution of acquisition talks, while risks involve management credibility and competitive pressures in aesthetic medicine markets.
USIG trades at $48.765 with minimal daily movement (+0.17%). Technical indicators show a bearish bias with moving averages signaling caution, though oscillators remain neutral. The stock faces resistance at $49 levels while finding support at $48. Recent institutional activity includes Blue Edge Capital's new $21.9 million position and Bank of New York Mellon's increased stake, indicating institutional confidence.
The bearish technical setup contrasts with institutional accumulation, creating a divergence worth monitoring. Key risks include market volatility and competitive pressures in the investment grade corporate bond ETF space. The absence of current fundamental metrics requires careful due diligence on underlying bond portfolio quality and interest rate sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →
